Xinyuan Real Estate (XIN)

[BettingAngles]

Xinyuan Real Estate Co., Ltd. Announces Quarterly Cash Dividend

-Company Raises Annualized Dividend Payment- -Moves from Annual to Quarterly Payment-

BEIJING, April 18, 2012 /PRNewswire via COMTEX/ -- Xinyuan Real Estate Co., Ltd. XIN -5.37% , a residential real estate developer with a focus on high growth, strategic Tier II & III cities in China, announced today that its Board of Directors has declared a quarterly cash dividend of US$0.02 per common share, or US$0.04 per American Depositary Share (ADS), payable May 15, 2012, to shareholders of record on April 30, 2012. This is equivalent to an annual cash dividend of US$0.08 per common share, or US$0.16 per ADS, which represents a substantial increase over the previous year's annual dividend of $0.10 per ADS.

Mr. Yong Zhang, Xinyuan's Chairman and Chief Executive Officer commented, "We are pleased to continue our cash dividend for the second consecutive year and to initiate distribution of our dividend payment on a quarterly basis going forward. Management's decision to increase the dividend demonstrates Xinyuan's financial health and operational strength despite the challenging property market environment in China. We remain confident in our future growth prospects and long-term financial strength."

About Xinyuan Real Estate Co., Ltd.

Xinyuan Real Estate Co., Ltd. ("Xinyuan") XIN -5.37% is a developer of large scale, high quality residential real estate projects aimed at providing middle-income consumers with a comfortable and convenient community lifestyle. Xinyuan focuses on China's Tier II cities, characterized as larger, more developed urban areas with above average GDP and population growth rates. Xinyuan has expanded its network to cover a total population of over 44.7 million people in seven strategically selected Tier II cities, comprising Hefei, Jinan, Kunshan, Suzhou, Zhengzhou, Xuzhou and Chengdu. Xinyuan is the first real estate developer from China to be listed on the New York Stock Exchange. For more information, please visit http://www.xyre.com .